Drug Profile
Research programme: diabetes/obesity therapies - Dompe
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Dompe Farmaceutici
- Class
- Mechanism of Action FFAR1 protein modulators; GPBAR1 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus; Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Diabetes-mellitus in Italy
- 16 Jul 2016 No recent reports of development identified for research development in Obesity in Italy
- 31 Mar 2011 Early research in Diabetes mellitus in Italy (unspecified route)